Global Fund To Stop Purchasing Generic Malaria Medication From Indian Manufacturer After U.S. Regulatory Warning
Reuters: India’s IPCA says Global Fund stops buying its anti-malarial drugs
“India’s IPCA Laboratories Ltd said on Thursday that the Global Fund to Fight AIDS, Tuberculosis and Malaria would no longer buy the company’s anti-malarial treatments after a U.S. regulatory warning about quality lapses at its factories…” (Wilkes, 4/7).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.